These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10662962)

  • 41. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping.
    Colloby SJ; Fenwick JD; Williams ED; Paling SM; Lobotesis K; Ballard C; McKeith I; O'Brien JT
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):615-22. PubMed ID: 11976799
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regional cerebral blood flow assessed with 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease.
    Encinas M; De Juan R; Marcos A; Gil P; Barabash A; Fernández C; De Ugarte C; Cabranes JA
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1473-80. PubMed ID: 14579086
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The investigation of dementia syndromes by 133Xenon dynamic single photon emission computed tomography.
    Reischies FM; Hedde JP; Gutzmann H
    Neurosurg Rev; 1987; 10(2):105-8. PubMed ID: 3502360
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The contribution of single photon emission tomography to the clinical differentiation of degenerative cortical brain disorders.
    Talbot PR; Snowden JS; Lloyd JJ; Neary D; Testa HJ
    J Neurol; 1995 Sep; 242(9):579-86. PubMed ID: 8551319
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cerebral glucose metabolism in patients with frontotemporal dementia.
    Ishii K; Sakamoto S; Sasaki M; Kitagaki H; Yamaji S; Hashimoto M; Imamura T; Shimomura T; Hirono N; Mori E
    J Nucl Med; 1998 Nov; 39(11):1875-8. PubMed ID: 9829574
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Imaging discrepancies between magnetic resonance imaging and brain perfusion single-photon emission computed tomography in the diagnosis of Alzheimer's disease, and verification with amyloid positron emission tomography.
    Yokoyama S; Kajiya Y; Yoshinaga T; Tani A; Hirano H
    Psychogeriatrics; 2014 Jun; 14(2):110-7. PubMed ID: 24954834
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SPECT for differential diagnosis of dementia and correlation of rCBF with cognitive impairment.
    Osimani A; Ichise M; Chung DG; Pogue JM; Freedman M
    Can J Neurol Sci; 1994 May; 21(2):104-11. PubMed ID: 8087734
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of diabetes-related dementia: Longitudinal perfusion SPECT and amyloid PET studies.
    Fukasawa R; Hanyu H; Shimizu S; Kanetaka H; Sakurai H; Ishii K
    J Neurol Sci; 2015 Feb; 349(1-2):45-51. PubMed ID: 25573776
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interpretation variability of 18FDG-positron emission tomography studies in dementia.
    Hoffman JM; Hanson MW; Welsh KA; Earl N; Paine S; Delong D; Coleman RE
    Invest Radiol; 1996 Jun; 31(6):316-22. PubMed ID: 8761863
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Choice of reference region in the quantification of single-photon emission tomography in primary degenerative dementia.
    Talbot PR; Lloyd JJ; Snowden JS; Neary D; Testa HJ
    Eur J Nucl Med; 1994 Jun; 21(6):503-8. PubMed ID: 8082664
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cognitive and brain imaging measures of Alzheimer's disease.
    Cutler NR
    Neurobiol Aging; 1988; 9(1):90-2. PubMed ID: 3260013
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [123I-IMP-SPECT finding of a case of presenile dementia with motor neuron disease--comparison between Alzheimer's disease, Pick's disease and presenile dementia with motor neuron disease].
    Mitsuyama Y
    Seishin Shinkeigaku Zasshi; 1989; 91(7):500-11. PubMed ID: 2608750
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Brain photon emission tomography. Value of the corticocerebellar index and gammagraphic patterns in Alzheimer's disease and other diseases].
    Domper M; Richter JA; Lacruz F; Arbizu J; Manubens JM; García MJ; Martínez-Lage M
    Med Clin (Barc); 1991 Jan; 96(1):1-5. PubMed ID: 2023461
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SPECT and PET imaging in Alzheimer's disease.
    Valotassiou V; Malamitsi J; Papatriantafyllou J; Dardiotis E; Tsougos I; Psimadas D; Alexiou S; Hadjigeorgiou G; Georgoulias P
    Ann Nucl Med; 2018 Nov; 32(9):583-593. PubMed ID: 30128693
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of molecular imaging on the diagnostic process in a memory clinic.
    Ossenkoppele R; Prins ND; Pijnenburg YA; Lemstra AW; van der Flier WM; Adriaanse SF; Windhorst AD; Handels RL; Wolfs CA; Aalten P; Verhey FR; Verbeek MM; van Buchem MA; Hoekstra OS; Lammertsma AA; Scheltens P; van Berckel BN
    Alzheimers Dement; 2013 Jul; 9(4):414-21. PubMed ID: 23164552
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is brain SPECT useful in degenerative dementia diagnosis?
    Farid K; Caillat-Vigneron N; Sibon I
    J Comput Assist Tomogr; 2011; 35(1):1-3. PubMed ID: 21160432
    [TBL] [Abstract][Full Text] [Related]  

  • 58. FDG PET imaging in patients with pathologically verified dementia.
    Hoffman JM; Welsh-Bohmer KA; Hanson M; Crain B; Hulette C; Earl N; Coleman RE
    J Nucl Med; 2000 Nov; 41(11):1920-8. PubMed ID: 11079505
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Iofetamine I 123 single photon emission computed tomography is accurate in the diagnosis of Alzheimer's disease.
    Johnson KA; Holman BL; Rosen TJ; Nagel JS; English RJ; Growdon JH
    Arch Intern Med; 1990 Apr; 150(4):752-6. PubMed ID: 2327836
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks.
    Varrone A; Pappatà S; Caracò C; Soricelli A; Milan G; Quarantelli M; Alfano B; Postiglione A; Salvatore M
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1447-54. PubMed ID: 12397463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.